JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Macher, B. A.
Right arrow Articles by Feizi, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Macher, B. A.
Right arrow Articles by Feizi, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 263, Issue 21, 10186-10191, 07, 1988

A novel carbohydrate, differentiation antigen on fucogangliosides of human myeloid cells recognized by monoclonal antibody VIM-2

BA Macher, J Buehler, P Scudder, W Knapp and T Feizi
Department of Chemistry, San Francisco State University, California 94132.

A mouse monoclonal antibody, VIM-2, specific for human blood cells of myelomonocytic lineage, was found to bind to a series of minor gangliosides isolated from the cells of patients with chronic myelogenous leukemia (Uemura, K., Macher, B.A., DeGregorio, M., Scudder, P., Buehler, J., Knapp, W., and Feizi, T. (1985) Biochim. Biophys. Acta 846, 26-36). TLC immunostaining studies with the VIM-2 antibody of gangliosides from normal human neutrophils, acute myeloid leukemia, and chronic myelogenous leukemia cells showed that the total amount and the ratio of the VIM-2 gangliosides varies among these different myeloid cells and appears to be related to the level of cellular differentiation. Purification of these gangliosides from chronic myelogenous leukemia cells was aided by a sensitive enzyme- linked immunosorbent assay procedure used in conjunction with high performance liquid chromatography. Structures for two of the immunoreactive gangliosides (a ceramide decasaccharide, VIII3NeuAcV3- Fuc-nLc8Cer and a ceramide dodecasaccharide X3-NeuAcVII3Fuc-nLc10Cer) are proposed from negative ion fast atom bombardment mass spectrometry of the native gangliosides, methylation analysis, and the combined use of glycosidase treatment and TLC immunostaining with carbohydrate sequence specific antibodies. The VIM-2 antigen was thus characterized as involving the sialofucooligosaccharide sequence.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Shetterly, F. Jost, S. R. Watson, R. Knegtel, B. A. Macher, and E. H. Holmes
Site-specific Fucosylation of Sialylated Polylactosamines by {alpha}1,3/4-Fucosyltransferases-V and -VI Is Defined by Amino Acids Near the N Terminus of the Catalytic Domain
J. Biol. Chem., August 24, 2007; 282(34): 24882 - 24892.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. K. Patnaik, B. Potvin, and P. Stanley
LEC12 and LEC29 Gain-of-Function Chinese Hamster Ovary Mutants Reveal Mechanisms for Regulating VIM-2 Antigen Synthesis and E-selectin Binding
J. Biol. Chem., November 26, 2004; 279(48): 49716 - 49726.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
M. J. Martin, T. Feizi, C. Leteux, D. Pavlovic, V. E. Piskarev, and W. Chai
An investigation of the interactions of E-selectin with fuco-oligosaccharides of the blood group family
Glycobiology, December 1, 2002; 12(12): 829 - 835.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-C. Huang, A. Laskowska, D. Vestweber, and M. K. Wild
The alpha (1,3)-Fucosyltransferase Fuc-TIV, but Not Fuc-TVII, Generates Sialyl Lewis X-like Epitopes Preferentially on Glycolipids
J. Biol. Chem., November 27, 2002; 277(49): 47786 - 47795.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Clarke and W. M. Watkins
alpha1,3-L-Fucosyltransferase Expression in Developing Human Myeloid Cells
J. Biol. Chem., April 26, 1996; 271(17): 10317 - 10328.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. L. Smith, K. M. Gersten, B. Petryniak, R. J. Kelly, C. Rogers, Y. Natsuka, J. A. Alford III, E. P. Scheidegger, S. Natsuka, and J. B. Lowe
Expression of the alpha(1,3)Fucosyltransferase Fuc-TVII in Lymphoid Aggregate High Endothelial Venules Correlates with Expression of L-Selectin Ligands
J. Biol. Chem., April 5, 1996; 271(14): 8250 - 8259.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
G Walz, A Aruffo, W Kolanus, M Bevilacqua, and B Seed
Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells
Science, November 23, 1990; 250(4984): 1132 - 1135.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
F. Nakayama, S. Nishihara, H. Iwasaki, T. Kudo, R. Okubo, M. Kaneko, M. Nakamura, M. Karube, K. Sasaki, and H. Narimatsu
CD15 Expression in Mature Granulocytes Is Determined by alpha 1,3-Fucosyltransferase IX, but in Promyelocytes and Monocytes by alpha 1,3-Fucosyltransferase IV
J. Biol. Chem., May 4, 2001; 276(19): 16100 - 16106.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1988 by the American Society for Biochemistry and Molecular Biology.